|
US5128459A
(en)
*
|
1988-02-08 |
1992-07-07 |
The General Hospital Corporation |
Isolation, purification, characterization, cloning and sequencing of N alpha-acetyltransferase
|
|
US5656458A
(en)
*
|
1988-11-04 |
1997-08-12 |
Chiron Corporation |
Expression and processing of amino terminus acetylated FGF's in yeast
|
|
US5223421A
(en)
*
|
1989-10-25 |
1993-06-29 |
The General Hospital Corporation |
Identification of methionine Nα-acetyltransferase
|
|
AU640428B2
(en)
*
|
1989-10-25 |
1993-08-26 |
General Hospital Corporation, The |
Isolating of strains of saccharomyces cerevisiae having altered nalpha-acetyltransferase activity
|
|
US20030220258A1
(en)
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
|
US8680059B2
(en)
*
|
1998-05-20 |
2014-03-25 |
Biotempt B.V. |
Oligopeptide acetate and formulations thereof
|
|
NO986133D0
(no)
*
|
1998-12-23 |
1998-12-23 |
Preben Lexow |
FremgangsmÕte for DNA-sekvensering
|
|
EP1300418A1
(en)
*
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
|
FR2807523B1
(fr)
*
|
2000-04-07 |
2002-08-30 |
Inst Nat Sante Rech Med |
UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE
|
|
US20030109457A1
(en)
*
|
2001-10-25 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
|
|
GB2368339B
(en)
*
|
2000-10-26 |
2002-09-18 |
Yissum Res Dev Co |
Complex incorporating a plurality of antioxidants
|
|
DE10106852A1
(de)
|
2001-02-14 |
2002-09-05 |
T Luger |
Entzündungshemmende Verbindungen
|
|
US7528227B2
(en)
*
|
2004-03-23 |
2009-05-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Histone H2A peptide derivatives and uses thereof
|
|
US20030083262A1
(en)
*
|
2001-08-30 |
2003-05-01 |
Praecis Pharmaceuticals Inc. |
Methods and compositions for treating inflammatory disorders
|
|
US7238671B2
(en)
*
|
2001-10-18 |
2007-07-03 |
Bristol-Myers Squibb Company |
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
|
|
US20080242837A1
(en)
*
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
|
US20080318871A1
(en)
*
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
|
US7786084B2
(en)
*
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
|
JP2006522328A
(ja)
*
|
2003-03-07 |
2006-09-28 |
ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク |
クロマトグラフ相の合成のための方法
|
|
WO2005051982A1
(ja)
*
|
2003-11-28 |
2005-06-09 |
Toagosei Co,. Ltd. |
糖ペプチド及び温度応答性ミセル
|
|
US20090227505A1
(en)
*
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
CN101010334B
(zh)
*
|
2004-08-30 |
2013-02-06 |
东丽株式会社 |
分级装置
|
|
ES2426441T3
(es)
*
|
2004-10-18 |
2013-10-23 |
Basf Beauty Care Solutions France S.A.S. |
Oligopéptidos y su uso en cosméticos
|
|
US7563764B2
(en)
*
|
2004-12-30 |
2009-07-21 |
E. I. Du Pont De Nemours And Company |
Antimicrobial peptides based on tripeptide repeats
|
|
EP2399599A3
(en)
|
2005-01-20 |
2012-04-18 |
Biomarck Pharmaceuticals, Ltd. |
Mucin hypersecretion inhibitors and methods of use
|
|
CN101217971B
(zh)
*
|
2005-07-05 |
2011-11-09 |
比奥滕普特公司 |
肿瘤的治疗
|
|
EP1782819A1
(en)
*
|
2005-11-03 |
2007-05-09 |
Cognis IP Management GmbH |
Oligopeptides and their use
|
|
TWI303567B
(en)
*
|
2005-12-20 |
2008-12-01 |
Ind Tech Res Inst |
Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
|
|
WO2007098033A2
(en)
|
2006-02-16 |
2007-08-30 |
University Of Georgia Research Foundation, Inc . |
Feedback prodrug
|
|
EP1987062B1
(en)
*
|
2006-02-23 |
2011-06-22 |
Fibrex Medical Research & Development GmbH |
Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
|
|
EP1864692A1
(en)
|
2006-06-07 |
2007-12-12 |
Biotempt B.V. |
Use of peptides for the control of radiation injury
|
|
FR2900826B1
(fr)
*
|
2006-05-12 |
2008-08-15 |
Soc Extraction Principes Actif |
Utilisation de peptides en tant que principes actifs amincissants.
|
|
BRPI0714953A2
(pt)
*
|
2006-07-26 |
2013-07-16 |
Biomarck Pharmaceuticals Ltd |
mÉtodos para atenuar a liberaÇço de mediadores inflamatàrios e peptÍdeos éteis nesse sentido
|
|
WO2008085828A2
(en)
*
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
WO2008100140A1
(en)
*
|
2007-02-12 |
2008-08-21 |
Biotempt B.V. |
Treatment of trauma hemorrhage with short oligopeptides
|
|
WO2010010551A2
(en)
*
|
2008-07-21 |
2010-01-28 |
Compugen Ltd. |
Novel angiopoietin derived peptides
|
|
FR2940969B1
(fr)
*
|
2009-01-09 |
2012-05-04 |
Isp Investments Inc |
Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
|
|
EP2507241A1
(en)
*
|
2009-12-02 |
2012-10-10 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Methanocarba adenosine derivatives and dendrimer conjugates thereof
|
|
EP2382963A1
(en)
*
|
2010-04-29 |
2011-11-02 |
Cognis IP Management GmbH |
Cosmetic composition containing oligopeptides
|
|
IN2013MN01582A
(pt)
|
2011-01-20 |
2015-06-12 |
Oneday Biotech And Pharma Ltd |
|
|
WO2012123018A1
(en)
*
|
2011-03-15 |
2012-09-20 |
Nanomed3D S.R.L. |
Functionalized biomaterials for tissue regeneration
|
|
KR101285259B1
(ko)
*
|
2011-08-04 |
2013-07-11 |
(주)케어젠 |
Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
|
|
US9452225B2
(en)
*
|
2012-03-01 |
2016-09-27 |
Novo Nordisk A/S |
GLP-1 prodrugs
|
|
EP2874641A4
(en)
|
2012-07-23 |
2016-10-12 |
Oneday Biotech And Pharma Ltd |
COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
|
|
EP2877194A4
(en)
|
2012-07-25 |
2016-03-16 |
Oneday Biotech And Pharma Ltd |
Compositions and methods for increasing carnitine concentration in muscle tissue
|
|
DK2891663T3
(en)
*
|
2012-08-31 |
2018-03-26 |
Vasculead Inc |
PSF1-Derived Peptide
|
|
CN104884078B
(zh)
*
|
2012-10-17 |
2017-06-20 |
诺和诺德股份有限公司 |
用于口服肽递送的脂肪酸酰化d‑氨基酸
|
|
WO2015173802A1
(en)
*
|
2014-05-11 |
2015-11-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Par-1 based therapeutic conjugates and uses thereof
|
|
KR101470793B1
(ko)
*
|
2014-06-30 |
2014-12-08 |
순천향대학교 산학협력단 |
흡수촉진제로서의 펩타이드와 이를 포함하는 조성물
|
|
WO2016129174A1
(ja)
*
|
2015-02-09 |
2016-08-18 |
株式会社ファーマフーズ |
ヒアルロン酸産生促進剤
|
|
US9856302B2
(en)
*
|
2015-07-23 |
2018-01-02 |
General Biologicals Corporation |
Anti-microbial peptide and method for treating microbial infection
|
|
EP3350200A4
(en)
*
|
2015-09-18 |
2019-03-27 |
Wake Forest University Health Services |
ANGIOTENSIN (1 7) ANALOGUE AND ASSOCIATED PROCEDURES
|
|
JP6684350B2
(ja)
*
|
2015-12-14 |
2020-04-22 |
ツァウ、イェウ−ピンＴＳＡＯ， Ｙｅｏｕ−Ｐｉｎｇ |
短い合成ペプチド及びその使用
|
|
US10286038B2
(en)
*
|
2016-03-11 |
2019-05-14 |
Northwestern University |
Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
|
|
DK3454879T3
(da)
*
|
2016-05-10 |
2022-03-14 |
Inst Nat Sante Rech Med |
Hidtil ukendte forbindelser og farmaceutisk anvendelse deraf i behandlingen af kræft
|
|
US10981980B2
(en)
*
|
2016-06-15 |
2021-04-20 |
Counterpoint Biomedica Llc |
Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
|
|
WO2018045155A1
(en)
*
|
2016-09-02 |
2018-03-08 |
The Board Of Trustees Of The University Of Illinois |
Kif13b-derived peptide and method of inhibiting angiogenesis
|
|
JP2020513418A
(ja)
*
|
2016-12-13 |
2020-05-14 |
エモリー ユニバーシティ |
ウイルス感染を管理するためのポリペプチド
|
|
US11116817B2
(en)
*
|
2017-02-17 |
2021-09-14 |
The Curators Of The University Of Missouri |
Antimicrobial agents and compositions comprising the same
|
|
US10570177B2
(en)
*
|
2017-03-01 |
2020-02-25 |
The Chinese University Of Hong Kong |
P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
|
|
RU2678987C2
(ru)
*
|
2017-04-28 |
2019-02-05 |
Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" |
Пептид для лечения болезни альцгеймера
|
|
EP3628047A1
(en)
*
|
2017-05-02 |
2020-04-01 |
Sanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
|
EP3787661B1
(en)
|
2018-05-02 |
2023-10-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Combination of temozolomide and a par-1 conjugate for treating glioblastoma
|
|
KR102234027B1
(ko)
*
|
2018-05-09 |
2021-03-31 |
서울대학교산학협력단 |
B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도
|
|
KR20220004618A
(ko)
*
|
2019-01-07 |
2022-01-11 |
세나 바이오사이언스 아이엔씨. |
신규한 펩티드 및 이의 용도
|
|
US11685766B2
(en)
|
2019-05-08 |
2023-06-27 |
Creighton University |
14-3-3 targeting peptides for cancer treatment
|
|
US11518784B2
(en)
*
|
2019-05-08 |
2022-12-06 |
Creighton University |
14-3-3 targeting peptides for cancer treatment
|
|
AU2020298130A1
(en)
|
2019-06-17 |
2022-01-20 |
Biomarck Pharmaceuticals Ltd. |
Peptides and methods of use thereof in treating uveitis
|
|
US20210009639A1
(en)
|
2019-07-12 |
2021-01-14 |
Northwestern University |
Insulin like growth factor binding protein bioactive peptide fragments
|
|
WO2024196750A1
(en)
*
|
2023-03-17 |
2024-09-26 |
Trustees Of Boston University |
Novel polypeptide bax/npm inhibitors
|